Red light signals danger

Article

It is an accepted fact that people in the UK have one of the poorest diets in Europe; with the consumption of poor-quality, low-priced foods, along with lack of exercise fuelling the rise in obesity amongst many other diseases.

In a bid to promote healthier eating, the UK Food Standards Agency has introduced a new kind of food labelling, which uses traffic light colours to signal whether a food item is healthy or not. The idea is to inform the consumer, at first glance, whether fat, saturated fat, sugar and salt content is high (red), medium (amber) or low (green).

Although this system is facing intense opposition from, amongst others, food manufacturers and some supermarket chains that are reluctant to introduce such a labelling system, it may represent a simple and effective method of promoting healthy eating to UK residents, irrespective of their age, education and social background.

Time and time again, patient communication and education has revealed itself as a challenging aspect of an ophthalmologist's profession; some ophthalmologists have worked hard to create patient education tools that will assist them in their communications. It's often forgotten, however, that sometimes the best and most effective way of communicating, is the simplest and the cheapest way.

I recently saw some patient education tools that a retina specialist successfully implemented in his practice to aid AMD patient self-monitoring. His method not only helped patients and relatives to become involved through the course of treatment and follow-up, but it also helped reduce unnecessary appointments made by anxious patients. Likewise, it also highlighted worrying cases quickly.

Whether this traffic light labelling system will prove successful in the UK is uncertain, however, it certainly teaches us that the simplest methods of communication are often the best.

Happy reading.

Fedra PavlouEditorfpavlou@advanstar.com

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.